Sinopharm Accord released its 2026 interim results flash. The company achieved total operating revenue of 36.266 billion yuan, down 1.44% year on year. Net profit attributable to the parent was about 606 million yuan, down 8.97% year on year. The distribution segment achieved operating revenue of 26.539 billion yuan, down 0.91% year on year, with net profit of 460 million yuan, down 4.56% year on year. The retail segment achieved operating revenue of 10.227 billion yuan, down 2.40% year on year, with the decline narrowing, and net profit of 13 million yuan, down 19.74% year on year.
China National Accord Medicines Corp LtdNet profit attributable to parent down 8.97% year on year.
